Vertex Pharma (NASDAQ: VRTX) 30-day option implied volatility is at 29; compared to its 52-week range of 18 to 334into acquiring Alpine Immune Sciences (ALPN) for $65 per share. Call put ratio 1 call to 6.2 puts with focus on April 430 and 440 puts.